Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi
Journal of the American Society for Mass Spectrometry · 2025
DOI: 10.1021/jasms.4c00382 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, 2025. Written by Christian A Rosales and 8 co-authors. Institution: Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada. Major MEDLINE topics: Amphetamines, Analgesics, Opioid, Hallucinogens, Substance Abuse Detection. 45 references. Funded by: Carleton University, Canada Foundation for Innovation, Ontario Research Foundation.
Abstract (original language)
Substances of misuse are becoming increasingly difficult to analyze as unique methods of smuggling are adopted and due to the rapid emergence of new psychoactive substances, increasing the pool of compounds to characterize and identify. Technologies such as gas chromatography and liquid chromatography coupled to mass spectrometry (MS) represent the gold standard for accurate and robust analysis, with on-site ambient- and portable-MS systems providing rapid methods of drug screening and testing. For many samples containing residual analyte quantities, methods to improve sensitivity through chemical derivatization are critical for accurate determination. Herein, we demonstrate for the first time the use of trimethylation enhancement using diazomethane (TrEnDi) to improve the MS-based sensitivity of 13 different drugs of misuse. All analytes were successfully permethylated, with 11 demonstrating improved analytical characteristics from TrEnDi with MS sensitivity enhancements ranging from 1.2-fold to as high as 24.2-fold in the case of psilocybin, as well as increases in reversed-phase chromatographic retention for most species. Derivatization using 13C-isotopically labeled TrEnDi reagents were used to successfully resolve isobaric interference issues between three pairs of controlled substances. By using an unconventional aprotic solvent system for electrospray ionization, the benefit of a fixed-permanent positive charge was highlighted as TrEnDi-modified amphetamine was easily measured while unmodified was not detected. Finally, TrEnDi was employed to boost the sensitivity of morphine in a real urine matrix. Our results demonstrate a percent recovery of 103.1% and a sensitivity enhancement of 2.4-fold, demonstrating the versatility and applicability of TrEnDi to pre-existing analytical workflows for trace analysis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada.
- Carleton Mass Spectrometry Centre, Carleton University, Ottawa, Ontario K1S 5B6, Canada.
- Institute of Biochemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada.
ORCID profiles: Benjamin B Warnes, Jasmine Chihabi, Jeffrey M Manthorpe, Jeffrey C Smith
Funding
- Carleton University
- Canada Foundation for Innovation
- Ontario Research Foundation
- Natural Sciences and Engineering Research Council of Canada
- Government of Ontario
Cite
APA
Rosales, C. A., Lepinsky, N. A., Gebeyehu, W., Wasslen, K. V., Colquhoun, F., Warnes, B. B., Chihabi, J., Manthorpe, J. M., & Smith, J. C. (2025). Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.4c00382
Vancouver
Rosales CA, Lepinsky NA, Gebeyehu W, Wasslen KV, Colquhoun F, Warnes BB, et al. Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.4c00382
BibTeX
@article{Rosales2025,
author = {Rosales, Christian A and Lepinsky, Noah A and Gebeyehu, Wondewossen and Wasslen, Karl V and Colquhoun, Fraser and Warnes, Benjamin B and Chihabi, Jasmine and Manthorpe, Jeffrey M and Smith, Jeffrey C},
title = {Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2025},
doi = {10.1021/jasms.4c00382}
}
EUVIMED